Product Program year 2025 Source: CMS Open Payments

MENTOR MemoryGel Resterilizable Gel Sizer

Device Plastic Surgery

PDI 00081317008330

Open in the dashboard

General payments

$2,254,083

34,603 payments

Research payments

$9,823,966

7,596 payments

Through program year 2025, $2,254,083 in general payments and $9,823,966 in research payments were reported against MENTOR MemoryGel Resterilizable Gel Sizer (Plastic Surgery).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

10 rows
Year Kind Amount Payments
2025 General $462,428 7,033
2025 Research $3,553,328 2,910
2024 General $623,834 7,404
2024 Research $1,120,128 864
2023 General $499,174 7,549
2023 Research $1,088,673 1,529
2022 General $426,830 6,862
2022 Research $1,196,677 1,358
2021 General $241,817 5,755
2021 Research $2,865,160 935

Breakdown

Who paid General payments · program years 2021–2025
  1. Mentor Worldwide LLC $2,234,310 34,447 payments
  2. Medical Device Business Services, Inc. $18,819 139 payments
  3. Johnson and Johnson International $731 13 payments
  4. DePuy Synthes Sales Inc. $155 1 payment
  5. Biosense Webster, Inc. $47 2 payments
  6. Johnson & Johnson Surgical Vision, Inc. $21 1 payment
Top recipients General payments · program year 2025
  1. Brian Thornton Plastic and Reconstructive Surgery · Louisville, KY $23,498 5% · 24 payments
  2. Essie Kueberuwa Yates Plastic Surgery · Weston, FL $18,663 4% · 13 payments
  3. Dennis Hammond Plastic Surgery · Grand Rapids, MI $15,395 3% · 9 payments
  4. Tamir Mosharrafa Plastic and Reconstructive Surgery · Phoenix, AZ $11,506 2% · 19 payments
  5. Cedars-Sinai Medical Center Teaching hospital · CA $7,500 2% · 1 payment

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Plastic Surgery $202,848 49% · 1,210 practitioners
  2. Plastic and Reconstructive Surgery Surgery $141,027 34% · 710 practitioners
  3. Surgery $13,868 3% · 147 practitioners
  4. Physician Assistant $11,948 3% · 168 practitioners
  5. Physician Assistant, Surgical Physician Assistant $7,527 2% · 82 practitioners

The top 5 of 81 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Florida $67,316 15% · 355 recipients
  2. California $58,985 13% · 339 recipients
  3. Texas $41,106 9% · 235 recipients
  4. Michigan $27,528 6% · 115 recipients
  5. Kentucky $26,513 6% · 43 recipients

The top 5 of 50 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

34,603 general · 7,596 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record